CIITA and neoplasm: pDCs from tumor-bearing mouse brain, blood, lymph node (LN), and bone marrow (BM) one-week post-intracranial tumor implantation were analyzed for the presence of activating markers (MHC-II and CIITA) and compared between tumor-bearing (red) and normal (black) mice (Figure 3A,B).